drugset / Trial / NCT05045638

Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants

NCT05045638

Phase 1 Completed 13 enrolled Amgen
Non-randomizedCrossoverOpen-labelBasic science

Summary

A study to determine the effect of sotorasib on the pharmacokinetics (PK) of rosuvastatin, and to assess the PK of rosuvastatin when administered alone, in healthy participants.

Timeline

Start
2021-08-20
Primary completion
2021-10-10
Completion
2021-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule Oral
Subject Sotorasib Small molecule Oral

Indications

No indication recorded.